1
|
Suphaphiphat K, Bernard-Stoecklin S, Gommet C, Delache B, Dereuddre-Bosquet N, Kent SJ, Wines BD, Hogarth PM, Le Grand R, Cavarelli M. Innate and Adaptive Anti-SIV Responses in Macaque Semen: Implications for Infectivity and Risk of Transmission. Front Immunol 2020; 11:850. [PMID: 32528466 PMCID: PMC7247827 DOI: 10.3389/fimmu.2020.00850] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2019] [Accepted: 04/14/2020] [Indexed: 12/16/2022] Open
Abstract
HIV-1 infection is transmitted primarily by sexual exposure, with semen being the principal contaminated fluid. However, HIV-specific immune response in semen has been understudied. We investigated specific parameters of the innate, cellular, and humoral immune response that may affect semen infectivity in macaques infected with SIVmac251. Serial semen levels of cytokines and chemokines, SIV-specific antibodies, neutralization, and FcγR-mediated functions and SIV-specific T-cell responses were assessed and compared to systemic responses across 53 cynomolgus macaques. SIV infection induced an overall inflammatory state in the semen. Several pro-inflammatory molecules correlated with SIV virus levels. Effector CD8+ T cells were expanded in semen upon infection. SIV-specific CD8+ T-cells that expressed multiple effector molecules (IFN-γ+MIP-1β+TNF+/-) were induced in the semen of a subset of SIV-infected macaques, but this did not correlate with local viral control. SIV-specific IgG, commonly capable of engaging the FcγRIIIa receptor, was detected in most semen samples although this positively correlated with seminal viral load. Several inflammatory immune responses in semen develop in the context of higher levels of SIV seminal plasma viremia. These inflammatory immune responses could play a role in viral transmission and should be considered in the development of preventive and prophylactic vaccines.
Collapse
Affiliation(s)
- Karunasinee Suphaphiphat
- CEA-Université Paris Sud-INSERM U1184, “Immunology of Viral Infections and Auto-Immune Diseases”, IDMIT Department, IBFJ, Fontenay-aux-Roses, France
| | - Sibylle Bernard-Stoecklin
- CEA-Université Paris Sud-INSERM U1184, “Immunology of Viral Infections and Auto-Immune Diseases”, IDMIT Department, IBFJ, Fontenay-aux-Roses, France
| | - Céline Gommet
- CEA-Université Paris Sud-INSERM U1184, “Immunology of Viral Infections and Auto-Immune Diseases”, IDMIT Department, IBFJ, Fontenay-aux-Roses, France
| | - Benoit Delache
- CEA-Université Paris Sud-INSERM U1184, “Immunology of Viral Infections and Auto-Immune Diseases”, IDMIT Department, IBFJ, Fontenay-aux-Roses, France
| | - Nathalie Dereuddre-Bosquet
- CEA-Université Paris Sud-INSERM U1184, “Immunology of Viral Infections and Auto-Immune Diseases”, IDMIT Department, IBFJ, Fontenay-aux-Roses, France
| | - Stephen J. Kent
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia
- Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia
- ARC Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Parkville, VIC, Australia
| | - Bruce D. Wines
- Immune Therapies Group, Burnet Institute, Melbourne, VIC, Australia
- Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia
- Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia
| | - P. Mark Hogarth
- Immune Therapies Group, Burnet Institute, Melbourne, VIC, Australia
- Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia
- Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia
| | - Roger Le Grand
- CEA-Université Paris Sud-INSERM U1184, “Immunology of Viral Infections and Auto-Immune Diseases”, IDMIT Department, IBFJ, Fontenay-aux-Roses, France
| | - Mariangela Cavarelli
- CEA-Université Paris Sud-INSERM U1184, “Immunology of Viral Infections and Auto-Immune Diseases”, IDMIT Department, IBFJ, Fontenay-aux-Roses, France
| |
Collapse
|
2
|
Antiviral antibodies and T cells are present in the foreskin of simian immunodeficiency virus-infected rhesus macaques. J Virol 2012; 86:7098-106. [PMID: 22532691 DOI: 10.1128/jvi.00410-12] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
No information exists regarding immune responses to human immunodeficiency virus (HIV) infection in the foreskin or glans of the human penis, although this is a key tissue for HIV transmission. To address this gap, we characterized antiviral immune responses in foreskin of male rhesus macaques (RMs) inoculated with simian immunodeficiency virus (SIV) strain SIVmac251 by penile foreskin exposure. We found a complete population of immune cells in the foreskin and glans of normal RMs, although B cells were less common than CD4(+) and CD8(+) T cells. IgG-secreting cells were detected by enzyme-linked immunospot (ELISPOT) assay in cell suspensions made from the foreskin. In the foreskin and glans of SIV-infected RMs, although B cells were less common than CD4(+) and CD8(+) T cells, SIV-specific IgG antibody was present in foreskin secretions. In addition, cytokine-secreting SIV-specific CD8(+) T cells were readily found in cell suspensions made from the foreskin. Although potential HIV target cells were found in and under the epithelium covering all penile surfaces, the presence of antiviral effector B and T cells in the foreskin suggests that vaccines may be able to elicit immunity in this critical site to protect men from acquiring HIV.
Collapse
|
3
|
Olivier AJ, Liebenberg LJ, Coetzee D, Williamson AL, Passmore JAS, Burgers WA. Isolation and characterization of T cells from semen. J Immunol Methods 2011; 375:223-31. [PMID: 22094241 DOI: 10.1016/j.jim.2011.11.001] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2011] [Revised: 10/31/2011] [Accepted: 11/02/2011] [Indexed: 01/25/2023]
Abstract
BACKGROUND The male genital tract is of major importance in the transmission and acquisition of HIV-1. Studying cellular immunity in the male genital tract is important in development of HIV-1 vaccines protective at mucosal sites. Semen is the primary HIV-1 containing fluid released from the male genital tract and reducing virus levels in semen would also reduce HIV-1 spread. Characterizing lymphocytes from semen requires the isolation of viable T cells that can be analyzed by downstream applications such as flow cytometry. The aims of this study were to investigate the influence of various parameters on CD3(+) T cell yields from semen and to compare isolation methods to maximize CD3(+) T cell yields for the purpose of functional characterization by flow cytometry. METHODS The influence of abstinence, storage temperature and time till processing on semen CD3(+) T cell yields was investigated. Seminal CD3(+) T cell yields were evaluated by comparing gradient separation, enzymatic digestion, filtration and magnetic bead capture. The function and viability of seminal CD4(+) and CD8(+) T cells were assayed by flow cytometry. RESULTS We found that the use of pronase and cell strainers resulted in significantly higher CD3(+) T cell yields when compared to gradient separation alone. Positive selection of CD3(+) cells using magnetic bead purification resulted in significantly higher yields and improved resolution of lymphocyte subsets by flow cytometry. Processing of samples should occur as expediently as possible to maximize CD3(+) T cell yields. However, if this is not possible, loss of CD3(+) T cells can be minimized by storing samples at 37°C for up to one day post ejaculation. CONCLUSIONS We describe a simple method for the isolation of functional T cells from semen. Developing standardized methods for processing samples and measuring immunity in the male genital tract may be important in clinical trials of not only candidate HIV-1 vaccines, but in better understanding cellular immunity to a range of sexually transmitted infections of global significance.
Collapse
Affiliation(s)
- Abraham J Olivier
- Institute of Infectious Diseases and Molecular Medicine and Division of Medical Virology, University of Cape Town, Observatory 7925, Cape Town, South Africa
| | | | | | | | | | | |
Collapse
|
4
|
Abstract
PURPOSE OF REVIEW This review summarizes recent literature in the field of mucosal immunology as it applies to HIV transmission and pathogenesis. RECENT FINDINGS Pertinent recent findings include elucidation of the role of mucosal antigen-presenting cells and retinoic acid in imprinting a gut-homing phenotype on antigen-specific T and B cells, and the identification of Th17 and T regulatory cells as key modulators of the balance between tolerance and inflammation in mucosal tissues. SUMMARY Mucosal surfaces of the body serve as the major portal of entry for HIV. These tissues also house a majority of the body's lymphocytes, including the CD4 T-cells that are the major cellular target for HIV infection. Elucidating mucosal immune responses is critical to our understanding of the host-pathogen relationship for two reasons: first, mucosal barriers are defended by a range of innate and adaptive defenses that might be exploited to develop effective vaccines or microbicides; second, adaptive immune responses in mucosal lymphoid tissues might serve to limit viral replication, decreasing the host's viral burden as well as reducing the likelihood of sexual transmission to a naïve host.
Collapse
Affiliation(s)
- Barbara L Shacklett
- Department of Medical Microbiology and Immunology, University of California, Davis, California, USA.
| |
Collapse
|